Literature DB >> 10052477

Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?

M Blüthner1, A Brüntgens, S Schmidt, K Strojek, W Grzeszczak, E Ritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10052477     DOI： 10.1093/ndt/14.1.56

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Katrin Uhlig; George N Koukoulis; Afroditi A Papathanasiou; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

Review 2.  Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Na-Na Yang; Le-Qun Li
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

3.  Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.

Authors:  Tao Huang; JingJing Ren; Jinyan Huang; Duo Li
Journal:  BMC Genomics       Date:  2013-12-10       Impact factor: 3.969

4.  Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.

Authors:  Yanzi Meng; Xiaoling Liu; Kai Ma; Lili Zhang; Mao Lu; Minsu Zhao; Min-Xin Guan; Guijun Qin
Journal:  Mol Genet Genomic Med       Date:  2019-10-30       Impact factor: 2.183

5.  Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.

Authors:  Hui Guan; Meng-Di Xia; Miao Wang; Ying-Jie Guan; Xiao-Chen Lyu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.